SAN DIEGO, July 11 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will report second quarter 2006 financial results after the Nasdaq market closes Monday, July 17, 2006. A live conference call and webcast will follow at 5:00 p.m. Eastern/2:00 p.m. Pacific. Participants can access the live conference call by dialing 800-540-0559 (US) or 785-832-0326 (International) using the conference ID# NBIX. The call can also be accessed via the webcast through the Company’s website at http://www.neurocrine.com
If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Woodworth or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 877-710-5301 (US) or 402-220-1604 (International). The call will be archived until Monday, July 31, 2006.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, +1-858-617-7600, both ofNeurocrine Biosciences, Inc.
Web site: http://www.neurocrine.com/
